Robert F. Kennedy Jr.

FDA panel meets Wednesday to vote on access to seven unproven peptides

The Food and Drug Administration's Pharmacy Compounding Advisory Committee will convene on July 23–24 to vote on whether seven popular but unapproved peptides should be added to the Section 503A Bulk Drug Substances List, a move that would allow licensed…

You're all caught up

You've seen all the main stories from the past 2 days.